- 101. 2-Propanol-1-[(1-methylethyl)amino]-3-(1-naphthalenyloxy) Hydrochloride
- [The hydrochloride form of propranolol, a synthetic beta-adrenergic receptor blocker with antianginal, antiarrhythmic, antihypertensive properties. Propranolol competitively antagonizes beta-adrenergic receptors, thereby inhibiting beta-adrenergic reactions, such as vasodilation, and negative chronotropic and inotropic effects. ( NCI )] (UMLS (NCI) C0282321) =Organic Chemical; Pharmacologic Substance ;
=1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol;
=PROPRANOLOL HYDROCHLORIDE 60 MG;
PROPRANOLOL HYDROCHLORIDE 80 MG;
PROPRANOLOL HYDROCHLORIDE 120 MG;
PROPRANOLOL HYDROCHLORIDE 160 MG;
PROPRANOLOL HYDROCHLORIDE 80 MG/ML;
PROPRANOLOL HYDROCHLORIDE 1 MG/ML;
PROPRANOLOL HYDROCHLORIDE 20 MG/5ML;
PROPRANOLOL HYDROCHLORIDE 40 MG/5ML;
PROPRANOLOL HYDROCHLORIDE 10 MG;
PROPRANOLOL HYDROCHLORIDE 40 MG;
PROPRANOLOL HYDROCHLORIDE 20 MG;
PROPRANOLOL HYDROCHLORIDE 90 MG | - 151. 3-Phenylacetylamino-2, 6-piperidinedione
- [A piperidinedione antineoplaston with potential antineoplastic activity. Antineoplaston A10 was originally isolated from human urine but is now synthetically derived. This agent intercalates into DNA, resulting in cell cycle arrest in G1 phase, reduction of mitosis, and decreased protein synthesis. Antineoplaston A10 may also inhibit ras-oncogene expression and activate tumor suppressor gene p53, leading to cell differentiation and apoptosis. (NCI04) ( NCI )] (UMLS (NCI) C0052080) =Organic Chemical; Pharmacologic Substance ;
|
- 102. 2-Propanone
- [colorless liquid used as a solvent and an antiseptic; one of the ketone bodies produced during ketoacidosis. ( CSP )] (UMLS (NCI) C0001002) =Organic Chemical; Pharmacologic Substance ;
| - 152. 3-Phosphoinositide Dependent Protein Kinase-1
- [3-Phosphoinositide Dependent Protein Kinase-1, encoded by the PDPK1 gene, belongs to the Ser/Thr family of protein kinases. This protein phosphorylates and activates not only PKB/AKT, but also PKA, PKC-zeta, p70S6K and p90S6K/RSK. It may play a general role in signaling processes and in development (by similarity). It becomes cytoplasmic and membrane-associated after cell stimulation leading to its translocation. Tyrosine phosphorylation seems to occur only at the plasma membrane. Three isoforms exist from alternative splicing and Isoform 3 is catalytically inactive. (from LocusLink) ( NCI )] (UMLS (NCI) C0541150) =Amino Acid, Peptide, or Protein; Enzyme
|
- 103. 2-Propenamide
- [colorless, odorless, highly water soluble vinyl monomer formed from the hydration of acrylonitrile; primarily used in research laboratories for electrophoresis, chromatography, and electron microscopy and in the sewage and wastewater treatment industries. ( CSP )] (UMLS (NCI) C0050587) =Organic Chemical; Hazardous or Poisonous Substance ;
=amide;
=polyacrylamide;
| - 153. 3-Phosphoinositide Dependent Protein Kinase-1 Gene
- [This gene plays a role in cellular signaling and development. ( NCI )] (UMLS (NCI) C1335204) PDPK1;
PDPK1 Gene =Gene or Genome |
- 104. 2-Propenenitrile
- [AK-rih-low-NYE-tril A substance used to make plastics, rubber, and textiles. Exposure to acrylonitrile may increase the risk of developing certain cancers (such as lung, brain, or prostate cancer). ( NCI )] (UMLS (NCI) C0001223) =Organic Chemical; Hazardous or Poisonous Substance ;
| - 154. 3-Pyridinecarboxamide
- [B complex vitamin used in the prophylaxis and treatment of pellagra; functions as a component of the coenzyme NAD (Nicotinamide-Adenine Dinucleotide). ( CSP )] (UMLS (NCI) C0028027) =Organic Chemical; Pharmacologic Substance; Vitamin =[VT103] NICOTINIC ACID;
3-Pyridinecarboxamide;
Nicotinic Acids;
[VT100] VITAMIN B;
TO BE DELETED INGREDIENT PREPARATIONS;
Unclassified Ingredient Preparations =3-Pyridinecarboxamide;
NICOTINAMIDE HYDRIODIDE;
NIACIN (AS NIACINAMIDE) 28 MG/L;
NIACIN (AS NIACINAMIDE) 3.33 MG;
NIACIN (AS NIACINAMIDE) 30 MG;
CITROTEIN POWDER (ORANGE);
MERITENE POWDER (CHOCOLATE);
MERITENE POWDER (MILK More… |
- 105. 2-Propylpentanoic Acid
- [A stable coordination compound comprised of sodium valproate and valproic acid with anticonvulsant and antiepileptic activities. Divalproex dissociates to the valproate ion in the gastrointestinal tract. This agent binds to and inhibits gamma-aminobutyric acid (GABA) transaminase and its anticonvulsant activity may be exerted by increasing brain concentration of GABA and by inhibiting enzymes that catabolize GABA or block the reuptake of GABA into glia and nerve endings. Divalproex may also work by suppressing repetitive neuronal firing through inhibition of voltage-sensitive sodium channels. ( NCI )] (UMLS (NCI) C0042291) =Lipid; Pharmacologic Substance ;
=[CN400] ANTICONVULSANTS;
Pentanoic Acids;
2-Propylpentanoic Acid;
=2-Propylpentanoic Acid;
2 propylvalerate;
DIVALPROEX SODIUM;
VALPROIC ACID 250 MG;
VALPROIC ACID 250 MG/5ML | - 155. 30p
- [Mandibular right first molar prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553625) =Medical Device =Artificial dentition;
|
- 106. 2-Propylpentanoic Acid Sodium Salt
- [The sodium salt form of valproic acid with anti-epileptic activity. Valproate sodium is converted into its active form, valproate ion, in blood. Although the mechanism of action remains to be elucidated, valproate sodium increases concentrations of gamma-aminobutyric acid (GABA) in the brain, probably due to inhibition of the enzymes responsible for the catabolism of GABA. This potentiates the synaptic actions of GABA. Valproate sodium may also affect potassium channels, thereby creating a direct membrane-stabilizing effect. ( NCI )] (UMLS (NCI) C0037567) =Lipid; Pharmacologic Substance ;
=2 propylvalerate;
=Sodium Valproate 100 MG/ML | - 156. 30pd
- [Mandibular right first molar distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553626) =Medical Device =Artificial dentition;
|
- 107. 2-[2-Propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5-hydroxyphenoxy]propoxy]phenoxy]benzoic Acid
- (UMLS (NCI) C0298617) =Organic Chemical; Pharmacologic Substance
| - 157. 30pm
- [Mandibular right first molar mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553624) =Medical Device =Artificial dentition;
|
- 108. 2-[p-(2-Chloro-1,2-diphenylvinyl)phenoxy]triethylamine
- [USP lists as a gonad stimulating principle; is a fertility inhibitor in male and female rats, but is a fertility stimulant in women used to induce multiple births. ( CSP )] (UMLS (NCI) C0009008) =Organic Chemical; Pharmacologic Substance ;
=fertility promoting drug;
[HS400] GONADOTROPINS;
[HS800] PROGESTINS;
stilbene =2-[p-(2-Chloro-1,2-diphenylvinyl)phenoxy]triethylamine Citrate;
| - 158. 31p
- [Mandibular right second molar prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553628) =Medical Device =Artificial dentition;
|
- 109. 2-[p-(2-Chloro-1,2-diphenylvinyl)phenoxy]triethylamine Citrate
- [The citrate salt form of clomiphene, a triphenylethylene nonsteroidal ovulatory stimulant evaluated for antineoplastic activity against breast cancer. Clomiphene has both estrogenic and anti-estrogenic activities that compete with estrogen for binding at estrogen receptor sites in target tissues. This agent causes the release of the pituitary gonadotropins follicle stimulating hormone (FSH) and luteinizing hormone (LH), leading to ovulation. (NCI04) ( NCI )] (UMLS (NCI) C0546859) =Organic Chemical; Pharmacologic Substance =2-[p-(2-Chloro-1,2-diphenylvinyl)phenoxy]triethylamine;
=CLOMIPHENE CITRATE 50 MG;
| - 159. 31pd
- [Mandibular right second molar distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553629) =Medical Device =Artificial dentition;
|
- 110. 20p
- [Mandibular left second premolar prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553595) =Medical Device =Artificial dentition;
| - 160. 31pm
- [Mandibular right second molar mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553627) =Medical Device =Artificial dentition;
|
- 111. 20pd
- [Mandibular left second premolar distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553594) =Medical Device =Artificial dentition;
| - 161. 32p
- [Mandibular right third molar prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553631) =Medical Device =Artificial dentition;
|
- 112. 20pm
- [Mandibular left second premolar mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553596) =Medical Device =Artificial dentition;
| - 162. 32pd
- [Mandibular right third molar distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553632) =Medical Device =Artificial dentition;
|
- 113. 21p
- [Mandibular left first premolar prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553598) =Medical Device =Artificial dentition;
| - 163. 32pm
- [Mandibular right third molar mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553630) =Medical Device =Artificial dentition;
|
- 114. 21pd
- [Mandibular left first premolar distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553597) =Medical Device =Artificial dentition;
| - 164. 3p
- [Maxillary right first molar prosthesis ( HL7V3.0 )] (UMLS (HL7) C1552216) =Body Part, Organ, or Organ Component =Artificial dentition;
|
- 115. 21pm
- [Mandibular left first premolar mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553599) =Medical Device =Artificial dentition;
| - 165. 3p
- [Proximal (short) arm of chromosome 3 ( NCI )] (UMLS (NCI) C0796477) Chromosome 3 Proximal Arm;
Chromosome 3 Short Arm;
Chromosome 3p =Nucleotide Sequence |
- 116. 22p
- [Mandibular left canine prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553601) =Medical Device =Artificial dentition;
| - 166. 3pd
- [Maxillary right first molar distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1552215) =Medical Device =Artificial dentition;
|
- 117. 22pd
- [Mandibular left canine distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553600) =Medical Device =Artificial dentition;
| - 167. 3pm
- [Maxillary right first molar mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1552217) =Medical Device =Artificial dentition;
|
- 118. 22pm
- [Mandibular left canine mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553602) =Medical Device =Artificial dentition;
| - 168. 4-(3-(p-Butoxyphenoxy)propyl)morpholine Hydrochloride
- [The hydrochloride salt form of pramoxine, a morpholine derivative with local anesthetic property. Pramoxine hydrochloride decreases the permeability of the neuronal membrane to sodium ions by reversibly binding to and inhibiting voltage-gated sodium channels. This results in stabilization of the membrane and , thereby inhibiting the ionic fluxes required for membrane depolarization, hence resulting in the failure to initiate a propagated action potential and subsequent conduction blockade. ( NCI )] (UMLS (NCI) C0147008) =Organic Chemical; Pharmacologic Substance =pramocaine;
=PRAMOXINE HYDROCHLORIDE 1 %WW;
PRAMOXINE HYDROCHLORIDE 10 MG/GM;
PRAMOXINE HYDROCHLORIDE 0.1 %;
PRAMOXINE HYDROCHLORIDE 0.5 %;
PRAMOXINE HYDROCHLORIDE 1 % |
- 119. 239PU
- [An artificial radioactive element with long half-life, Plutonium-239 is produced by bombarding uranium-238 with slow neutrons and is used as the explosive in nuclear weapons and as fuel for nuclear reactors. Similar to uranium, Plutonium-239 is a heavy, fissionable metal that accumulates in bones upon exposure and presents health hazards. Plutonium oxidation results in stable, easily inhaled, particulate plutonium dioxide that represents a respiratory health hazard. Plutonium ingestion is considerably less dangerous since little is absorbed in the digestive system. (NCI04) ( NCI )] (UMLS (NCI) C0303580) =Element, Ion, or Isotope ;
| - 169. 4-Pergamid
- (UMLS (NCI) C1328687) Pergamid;
=Organophosphorus Compound; Pharmacologic Substance ;
|
- 120. 23p
- [Mandibular left lateral incisor prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553604) =Medical Device =Artificial dentition;
| - 170. 4-Phenylbutyric Acid
- (UMLS (NCI) C0170531) =Organic Chemical
|
- 121. 23pd
- [Mandibular left lateral incisor distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553603) =Medical Device =Artificial dentition;
| - 171. 4-Piperidinecarboxylic Acid, 1-(3-cyano-3,3-diphenylpropyl)-4-phenyl-, Monohydrochloride
- [A phenylpiperidine with antidiarrheal activity and active metabolite of diphenoxylate. Difenoxin is chemically related to the narcotic opioid meperidine. Difenoxin hydrochloride acts primarily on the gastrointestinal wall by binding to opioid receptors on acetylcholine-containing nerves and inhibits the release of acetylcholine from presynaptic nerve terminals. This leads to a reduction in intestinal motility. Difenoxin hydrochloride also mimics the action of endogenous opioid peptides at the CNS opioid receptors, (primarily mu-receptors), thereby inducing CNS effects. ( NCI )] (UMLS (NCI) C0770333) Difenoxin Hydrochloride;
DIFENOXIN HYDROCHLORIDE PREPARATION;
Isonipecotic Acid, 1-(3-cyano-3,3-diphenylpropyl)-4-phenyl-, Hydrochloride =Organic Chemical; Pharmacologic Substance ;
=Difenoxin;
=DIFENOXIN HYDROCHLORIDE 1 MG;
|
- 122. 23pm
- [Mandibular left lateral incisor mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553605) =Medical Device =Artificial dentition;
| - 172. 4-Piperidinecarboxylic Acid, 1-(4-cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenyl-, Monohydrochloride,(-)-(1(cis)3alpha,4beta)-
- [The hydrochloride salt form of levocabastine, a synthetic piperidine derivative with antihistamine properties. Levocabastine is a second generation histamine-1 receptor antagonist. When applied locally into the eye as a topical solution, this agent reduces itching, rhinorrhea and symptoms of allergic rhinitis or conjunctivitis. ( NCI )] (UMLS (NCI) C0771194) Levocabastine Hydrochloride;
LEVOCABASTINE HYDROCHLORIDE PREPARATION;
R 50,547;
=Organic Chemical; Pharmacologic Substance =LEVOCABASTINE;
=LEVOCABASTINE HYDROCHLORIDE 0.05 %;
|
- 123. 24p
- [Mandibular left central incisor prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553607) =Medical Device =Artificial dentition;
| - 173. 4p
- [Maxillary right second premolar prosthesis ( HL7V3.0 )] (UMLS (HL7) C1552219) =Body Part, Organ, or Organ Component =Artificial dentition;
|
- 124. 24pd
- [Mandibular left central incisor distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553606) =Medical Device =Artificial dentition;
| - 174. 4pd
- [Maxillary right second premolar distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1552218) =Medical Device =Artificial dentition;
|
- 125. 24pm
- [Mandibular left central incisor mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553608) =Medical Device =Artificial dentition;
| - 175. 4pm
- [Maxillary right second premolar mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1552220) =Medical Device =Artificial dentition;
|
- 126. 25p
- [Mandibular right central incisor prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553610) =Medical Device =Artificial dentition;
| - 176. 5p
- [Maxillary right first premolar prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553550) =Body Part, Organ, or Organ Component =Artificial dentition;
|
- 127. 25pd
- [Mandibular right central incisor distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553611) =Medical Device =Artificial dentition;
| - 177. 5p Deletion Syndrome
- [infantile syndrome characterized by a cat-like cry, failure to thrive, microcephaly, mental retardation, spastic quadriparesis, micro- and retrognathia, glossoptosis, bilateral epicanthus, hypertelorism, and tiny external genitalia; caused by a deletion of the short arm of chromosome 5. ( CSP )] (UMLS (NCI) C0010314) =Congenital Abnormality; Disease or Syndrome =Abnormalities, Multiple;
Chromosomal anomalies;
syndrome;
Chromosomal Disorders, Nervous System |
- 128. 25pm
- [Mandibular right central incisor mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553609) =Medical Device =Artificial dentition;
| - 178. 5pd
- [Maxillary right first premolar distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553549) =Medical Device =Artificial dentition;
|
- 129. 26p
- [Mandibular right lateral incisor prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553613) =Medical Device =Artificial dentition;
| - 179. 5pm
- [Maxillary right first premolar mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553551) =Medical Device =Artificial dentition;
|
- 130. 26pd
- [Mandibular right lateral incisor distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553614) =Medical Device =Artificial dentition;
| - 180. 6 phosphofructokinase
- [An allosteric enzyme that regulates glycolysis by catalyzing the transfer of a phosphate group from ATP to fructose-6-phosphate to yield fructose-1,6-bisphosphate. D-tagatose- 6-phosphate and sedoheptulose-7-phosphate also are acceptors. UTP, CTP, and ITP also are donors. In human phosphofructokinase-1, three types of subunits have been identified. They are PHOSPHOFRUCTOKINASE-1, MUSCLE TYPE; PHOSPHOFRUCTOKINASE-1, LIVER TYPE; and PHOSPHOFRUCTOKINASE-1, C TYPE; found in platelets, brain, and other tissues. ( MSH )] (UMLS (CSP) C0031651) =Amino Acid, Peptide, or Protein; Enzyme ;
=alcohol phosphotransferase;
|
- 131. 26pm
- [Mandibular right lateral incisor mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553612) =Medical Device =Artificial dentition;
| - 181. 6-Propyl-2-thiouracil
- [A thiourea derivative with antithyroid property. Propylthiouracil (PTU) interferes with the oxidation of iodine possibly by interaction with peroxidase or a peroxidase-mediated complex reaction, thereby inhibiting synthesis of thyroid hormones tri-iodothyronine (T3) and thyroxine (T4). In addition, this agent inhibits the Type I 5'-deiodinase (D1), an enzyme involved in the peripheral conversion of thyroxine to tri-iodothyronine. This results in decreased plasma triodothyronine concentrations and decreased entrance of thyroxine into cells thereby reducing thyroid hormone activity. ( NCI )] (UMLS (NCI) C0033511) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance =thiouracil;
[HS852] ANTITHYROID AGENTS =PROPYLTHIOURACIL 50 MG;
|
- 132. 27p
- [Mandibular right canine prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553616) =Medical Device =Artificial dentition;
| - 182. 6p
- [Maxillary right canine prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553553) =Body Part, Organ, or Organ Component =Artificial dentition;
|
- 133. 27pd
- [Mandibular right canine distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553617) =Medical Device =Artificial dentition;
| - 183. 6pd
- [Maxillary right canine distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553552) =Medical Device =Artificial dentition;
|
- 134. 27pm
- [Mandibular right canine mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553615) =Medical Device =Artificial dentition;
| - 184. 6pm
- [Maxillary right canine mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553554) =Medical Device =Artificial dentition;
|
- 135. 28p
- [Mandibular right first premolar prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553619) =Medical Device =Artificial dentition;
| - 185. 7p
- [Maxillary right lateral incisor prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553556) =Body Part, Organ, or Organ Component =Artificial dentition;
|
- 136. 28pd
- [Mandibular right first premolar distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553620) =Medical Device =Artificial dentition;
| - 186. 7pd
- [Maxillary right lateral incisor distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553555) =Medical Device =Artificial dentition;
|
- 137. 28pm
- [Mandibular right first premolar mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553618) =Medical Device =Artificial dentition;
| - 187. 7pm
- [Maxillary right lateral incisor mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553557) =Medical Device =Artificial dentition;
|
- 138. 29p
- [Mandibular right second premolar prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553622) =Medical Device =Artificial dentition;
| - 188. 8p
- [Maxillary right central incisor prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553559) =Body Part, Organ, or Organ Component =Artificial dentition;
|
- 139. 29pd
- [Mandibular right second premolar distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553623) =Medical Device =Artificial dentition;
| - 189. 8p
- [Proximal (short) arm of chromosome 8 ( NCI )] (UMLS (NCI) C0796348) Chromosome 8 Proximal Arm;
Chromosome 8 Short Arm;
Chromosome 8p =Nucleotide Sequence |
- 140. 29pm
- [Mandibular right second premolar mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553621) =Medical Device =Artificial dentition;
| - 190. 8p22
- [A chromosome band present on 8p ( NCI )] (UMLS (NCI) C0796365) Chromosome 8p22 =Nucleotide Sequence
|
- 141. 2p
- [Maxillary right second molar prosthesis ( HL7V3.0 )] (UMLS (HL7) C1552213) =Body Part, Organ, or Organ Component =Artificial dentition;
| - 191. 8pd
- [Maxillary right central incisor distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553558) =Medical Device =Artificial dentition;
|
- 142. 2pd
- [Maxillary right second molar distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1552212) =Medical Device =Artificial dentition;
| - 192. 8pm
- [Maxillary right central incisor mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553560) =Medical Device =Artificial dentition;
|
- 143. 2pm
- [Maxillary right second molar mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1552214) =Medical Device =Artificial dentition;
| - 193. 9-(2-phophonylmethoxyethyl)adenine
- [an adenine analog, antiviral agent; used for treating hepatitis, HIV and African swine fever virus infections. ( CSP )] (UMLS (CSP) C0050175) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance =[AM800] ANTIVIRALS;
Reverse Transcriptase Inhibitor;
adenine analog;
Unclassified Ingredients =Adefovir Dipivoxil;
|
- 144. 2PP2A
- [Expressed by human SET Gene (NAP Family) in all tissues and responsive to serum factors, contact inhibition, or differentiation, 277-aa 32-kDa nuclear Phosphatase 2A Inhibitor I2PP2A is a specific inhibitor of PP2A that may be involved in intracellular signaling after ligand activation of HLA class II molecules. Serine phosphorylated SET has a long acidic C-terminus and SET domain. Located in an ER-associated complex containing pp32, HMG2, and APE1, SET is a specific inhibitor of GZMA-activated DNase/nucleoside diphosphate kinase (GAAD/NM23H1), which mediates GZMA-induced caspase-independent apoptosis characterized by single-stranded DNA nicks. GZMA cleavage of SET releases NM23H1 from bound inhibition to SET and results in SET degradation, NM23H1 translocation to the nucleus, and NM23H1 nicking of DNA. (NCI) ( NCI )] (UMLS (NCI) C1137947) HLA-DR Associated Protein II;
I2PP2A;
IGAAD;
Inhibitor of GZMA-Activated DNase;
PHAPII;
Phosphatase 2A Inhibitor I2PP2A;
SET;
SET Protein;
SET Translocation Inhibitor-2 of Protein Phosphatase-2A;
TAF-IBeta;
Template Activating Factor I Beta =Amino Acid, Peptide, or Protein; Biologically Active Substance | - 194. 9p
- [Maxillary left central incisor prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553562) =Body Part, Organ, or Organ Component =Artificial dentition;
|
- 145. 3 Prime Repair Exonuclease 1
- [TREX1 protein is phosphorylated by Ataxia Telangiectasia and Rad3 Related Protein (ATR), regulates ATR expression, and is an essential component of the DNA damage checkpoint pathway. TREX1 and ATR are mutually dependent partners in cell cycle checkpoint signaling pathways. The downstream ORF encodes isozymes that contain 3-prime-to-5-prime exonuclease activity and the excision of nucleotides from DNA 3-prime termini are required by DNA replication, repair, and recombination. They remove mismatched, modified, fragmented, and normal nucleotides to generate the appropriate 3-prime termini for subsequent steps in the DNA metabolic pathways. (NCI) ( NCI )] (UMLS (NCI) C0967200) ATR Interacting Protein;
ATR-Interacting Protein;
ATRIP;
Deoxyribonuclease III, DnaQ/MutD (E. coli)-Like;
DKFZp434J0310;
DNase III;
DRN3;
FLJ12343;
Three Prime Repair Exonuclease 1;
TREX1;
=Amino Acid, Peptide, or Protein; Enzyme ;
| - 195. 9pd
- [Maxillary left central incisor distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553563) =Medical Device =Artificial dentition;
|
- 146. 3,3',4',5,7-Pentahydroxyflavone
- (UMLS (NCI) C0910682) =Pharmacologic Substance ;
| - 196. 9pm
- [Maxillary left central incisor mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553561) =Medical Device =Artificial dentition;
|
- 147. 3,5-Pyrazolidinedione, 1,2-diphenyl-4-(2-(phenylsulfinyl)ethyl)-
- [A phenylbutazone derivative with uricosuric and antithrombotic properties. Sulfinpyrazone competitively inhibits reabsorption of urate at the proximal renal tubule in the kidney. This agent acts on the organic anion transport exchanger, thereby increasing uric acid excretion and decreasing serum uric acid levels resulting in the prevention of urate deposition. Sulfinpyrazone also blocks tubular excretion of various acidic drugs, resulting in increased serum concentration of the drugs. In addition, sulfinpyrazone and its active metabolite inhibit the synthesis of thromboxane A2, by competitively inhibiting the activity of cyclooxygenase, thereby preventing platelet aggregation through restoration of platelet survival time to normal, and decreasing platelet adhesiveness to subendothelial cells. ( NCI )] (UMLS (NCI) C0038742) =Organic Chemical; Pharmacologic Substance ;
=[MS400] ANTIGOUT AGENTS;
PHENYLBUTAZONE =SULFINPYRAZONE 100 MG;
SULFINPYRAZONE 200 MG | - 197. P
- [Mandibular right central primary incisor ( HL7V3.0 )] (UMLS (HL7) C0227095) =Body Part, Organ, or Organ Component =Primary dentition;
|
- 148. 3,5-Pyridinedicarboxylic Acid, 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-, Methyl 1-methylethyl Ester
- [A dihydropyridine calcium channel blockers with antihypertensive and vasodilator activity. Isradipine blocks the calcium entry through the calcium ion channels of coronary and peripheral vascular smooth muscle, thereby dilating coronary arteries and peripheral arterioles. This increases oxygen delivery due to an increased blood flow and reduces oxygen requirements due to decrease in total peripheral resistance. (NCI05) ( NCI )] (UMLS (NCI) C0071304) =Organic Chemical; Pharmacologic Substance ;
=[CV200] CALCIUM CHANNEL BLOCKERS;
Dihydropyridines;
[CV250] ANTIANGINALS;
=ISRADIPINE 2.5 MG;
ISRADIPINE 5 MG;
ISRADIPINE 10 MG | - 198. p aminobenzoate
- [member of the vitamin B complex although not an essential nutrient for humans; formerly a common sunscreen agent until found to also be a sensitizer; potassium salt is used therapeutically in fibrotic skin disorders. ( CSP )] (UMLS (CSP) C0178789) =Organic Chemical; Pharmacologic Substance ;
=benzoate;
=PROCAINE;
|
- 149. 3-(p-(bis(2-chloroethyl)amino)phenyl)-L-Alanine, Hydrochloride
- [A bifunctional alkylating agent and phenylalanine derivative of nitrogen mustard. Melphalan hydrochloride is converted into highly reactive ethylenimmonium intermediates that induce covalent guanine N7-N7 intra- and inter-crosslinks and alkylation of adenine N3 of DNA. This agent also alkylates RNA and protein structures. As a result RNA transcription and protein synthesis are inhibited, ultimately leading to cell growth arrest and/or death. ( NCI )] (UMLS (NCI) C0771055) Melphalan Hydrochloride;
MELPHALAN HYDROCHLORIDE PREPARATION =Organic Chemical; Pharmacologic Substance =4-[bis(2-chloroethyl)amino]-L-phenylalanine;
=MELPHALAN HYDROCHLORIDE 50 MG;
| - 199. p aminohippurate
- [ ] (UMLS (CSP) C0086761) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid =phenylamide;
|
- 150. 3-Phenyl-1H-naphtho[2,1-b]pyran-1-one
- [A polycyclic aromatic hydrocarbon that consists of a flavone group attached to a benzene ring. Beta-naphthoflavone is an inducer of the hepatic cytochrome p450 CYP1A1 and CYP1A2. ( NCI )] (UMLS (NCI) C0053490) =Organic Chemical; Pharmacologic Substance ;
| - 200. P-638
- (UMLS (NCI) C0918282) =Nucleic Acid, Nucleoside, or Nucleotide; Antibiotic ;
|
home
